By using single-photon emission computed tomography (SPECT) and positron emission tomography (PET), several studies have demonstrated the usefulness of radiolabeled GRP-R ligands in mouse breast cancer models as well as in estrogen receptor (ER)-positive breast tumor patients [227,228,229,230]. The gene discussed is ESR1; the disease is breast neoplasm.